01—Abstract
Summary
Summary of the 10-Q filed May 9, 2023. Cited figures are marked; the original filing is the authoritative source.
Axon Enterprise, Inc. reported strong revenue growth in the first quarter of 2023, with total net sales increasing by 33.8% year-over-year to $343.0 milliona.
This growth was driven by robust performance in both the Software and Sensors segment (+46.9%) and the TASER segment (+17.4%). The Software and Sensors segment, in particular, saw significant boosts from Axon Evidence and Cloud Services, as well as Axon Fleet Systems. Despite the impressive revenue increase, net income decreased to $45.1 millionb from $54.9 million in the prior year, primarily due to a notable increase in operating expenses, particularly in sales, general, and administrative (SG&A) and research and development (R&D), which rose by 29.3% and 46.5% respectively.
This increase in expenses was largely attributed to higher headcount, increased stock-based compensation, and higher salaries and benefits. The company ended the quarter with a healthy cash and cash equivalents balance of $263.4 millionc, though this was a decrease from the prior quarter.
Axon also highlighted its substantial remaining performance obligations of approximately $4.8 billiond, providing visibility into future contracted revenues. While the company faces ongoing risks related to supply chain, litigation, and macroeconomic conditions, its strategic investments in cloud-based solutions and continued expansion in the public safety technology market position it for sustained growth.
02—Key points
Key Highlights
- Total net sales increased by 33.8% to $343.0 million in Q1 2023 compared to Q1 2022.
- The Software and Sensors segment revenue grew by 46.9%, driven by Axon Evidence and Cloud Services and Axon Fleet Systems.
- TASER segment revenue increased by 17.4%, with significant contributions from cartridges and TASER devices.
- Operating expenses increased substantially, with SG&A up 29.3% and R&D up 46.5%, impacting profitability.
- Net income decreased to $45.1 million from $54.9 million year-over-year, impacted by higher operating expenses and a lower unrealized gain on investments compared to the prior year.
- Remaining performance obligations stand at approximately $4.8 billion, indicating strong future contracted revenue.
- The company maintained a strong liquidity position with $263.4 million in cash and cash equivalents at the end of the quarter.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2023, Axon Enterprise, Inc. kept $0.13.
- Revenue$344.3M100.0%
- Cost of revenue−$139.9M40.6%
- Gross profit$204.5M59.4%
- Operating costs−$186.9M54.3%
- Operating income$17.6M5.1%
- Interest, other & tax$28.3M8.2%
- Net income$45.9M13.3%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2023filed May 9, 2023Financial Statements
Q1 FY2023 against Q1 FY2022
| Line item | Q1 FY2023Q1 FY2022 | Change |
|---|---|---|
| Revenue | $344.34M$256.43M | +34.3% |
| Cost of Revenue | $139.88M$100.69M | +38.9% |
| Gross Profit | $204.46M$155.74M | +31.3% |
| R&D Expenses | $70.93M$48.42M | +46.5% |
| SG&A Expenses | $115.95M$90.13M | +28.6% |
| Operating Expenses | $186.87M$138.54M | +34.9% |
| Operating Income | $17.59M$17.19M | +2.3% |
| Net Income | $45.90M$54.87M | −16.4% |
| EPS (Basic) | $0.63$0.77 | −18.2% |
| EPS (Diluted) | $0.62$0.76 | −18.4% |
| Shares Outstanding (Basic) | 72.64M70.95M | +2.4% |
| Shares Outstanding (Diluted) | 73.88M72.35M | +2.1% |
05—Questions
Frequently Asked Questions
What were the main drivers of Axon's revenue growth in Q1 2023?
Axon's revenue growth was primarily driven by strong performance across both its segments. The Software and Sensors segment saw significant increases in Axon Evidence and Cloud Services, as well as Axon Fleet Systems. The TASER segment also contributed positively, with higher sales of cartridges and TASER devices, including the new TASER 10.
Why did net income decrease despite the significant revenue growth?
Net income decreased primarily due to a substantial increase in operating expenses. Sales, General, and Administrative (SG&A) expenses rose by 29.3% and Research and Development (R&D) expenses increased by 46.5%. These increases were driven by higher headcount, increased stock-based compensation, and rising salaries and benefits.
What is the significance of the $4.8 billion in remaining performance obligations?
The $4.8 billion in remaining performance obligations represents future contracted revenue that Axon expects to recognize over the next several years. This provides investors with visibility into the company's future revenue streams and demonstrates the strength of its long-term contracts, though it is subject to risks like delayed deployments and contract cancellations.
How has the company's liquidity and cash position changed?
As of March 31, 2023, Axon had $263.4 million in cash and cash equivalents, which represents a decrease of $90.3 million from December 31, 2022. This decrease is attributed to cash used in operating and investing activities, partially offset by financing activities. The company maintains a revolving credit facility of $200 million, providing additional liquidity if needed.
06—Continue